Asthma: New developments in cytokine regulation

Clinical and Experimental Immunology

Volumn 136, Issue 1, 2004, Pages 13-14

  Boyton, R J ^a,c   Altmann, D M ^b  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Asthma; NKT cell; SOCS 3; Stem cell factor; Th2 T cell

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN E; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; STAT5 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING; SUPPRESSOR OF CYTOKINE SIGNALING 3; UNCLASSIFIED DRUG;

ASTHMA; CHRONIC INFLAMMATION; CYTOKINE PRODUCTION; EDITORIAL; ENVIRONMENTAL FACTOR; GENETIC SUSCEPTIBILITY; HUMAN; PRIORITY JOURNAL; PUBLIC HEALTH; TH1 CELL; TH2 CELL;

ASTHMA; CYTOKINES; HUMANS; LUNG; TH2 CELLS;

EID: 1842560225     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2004.02452.x     Document Type: Editorial

References (17)

1. Umetsu D, McIntire J, Akbari O, Macaubas C, DeKruyf R. Asthma: an epidemic of dysregulated immunity. Nature Immunol 2002; 3:715-20.
2. Kay AB, Ying S, Varney V, Gaga M, Durham SR, Moqbel R, Wardlaw AJ, Hamid G. Messenger RNA expression of the cytokine gene cluster IL-3, IL-4, IL-5 and GM-CSF in allergen induced late phase cutaneous reactions in atopic subjects. J Exp Med 1991; 173:775-8.
3. Kay AB. Allergy and allergic diseases, part 1. N Engl J Med 2001; 344:30-7.
4. Van Eerdewegh P, Little RD, Dupuis J et al. Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness. Nature 2002; 418:426-30.
5. Hansen G, Berry G, DeKruyff RH, Umetsu DT. Allergen-specific Th1 cells fail to counterbalance Th2 cell-induced airway hyperreactivity but cause severe airway inflammation. J Clin Invest 1999; 103:175-83.
6. Kay AB. Immunomodulation in asthma: mechanisms and possible pitfalls. Curr Opin Pharmacol 2003; 3:220-6.
7. Akbari O, Stock P, Meyer E et al. Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity. Nature Med 2003; 9:582-8.
8. Seki Y, Inoue H, Nagata N et al. SOCS-3 regulates onset and maintenance of Th2-mediated allergic responses. Nature Med 2003; 9:1047-54.
9. Berlin AA, Lincoln P, Tomkinson A, Lukacs NW. Inhibition of stem cell factor reduces pulmonary cytokine levels during allergic airway responses. Clin Exp Immunol 2004; 136:15-20.
10. Kronenberg M, Gapin L. The unconventional lifestyle of NKT cells. Nat Rev Immunol 2002; 2:557-68.
11. Wilson SB, Kent SC, Patton KT et al. Extreme Th1 bias of invariant Vα24JαQ T cells in type I diabetes. Nature 1998; 391:177-81.
12. Nieuwenhuis EE, Matsumoto T, Exley M et al. CD1d-dependent macrophage-mediated clearance of Pseudomonas aeruginosa from lung. Nat Med 2002; 8:588-93.
13. Kubo M, Hanada T, Yoshimura A. Suppressors of cytokine signalling and immunity. Nat Immunol 2003; 4:1169-76.
14. Fujimoto M, Naka T. Regulation of cytokine signaling by SOCS family molecules. Trends Immunol 2003; 24:659-66.
15. Oliviera SHP, Taub DD, Nagel J, Smith R, Hogaboam CM, Berlin A, Lukacs NW. Stem cell factor induces eosinophil activation and degranulation: mediator release and gene array analysis. Blood 2002; 100:4291-7.
16. Oliviera SHP, Lukacs NW. Stem cell factor: a hemopoietic cytokine with important targets in asthma. Curr Drug Targets - Inflammation Allergy 2003; 2:313-8.
17. Zhang Z, Zhang R, Joachimiak A, Schlessinger J, Kong XP. Crystal structure of human stem cell factor: implication for stem cell factor receptor dimerization and activation. Proc Natl Acad Sci USA 2000; 97:7732-7.